Key Insights

Highlights

Treatment Research

3 treatments under study, led by 68gagaaby025 Pet

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Phase 1/2 (1)
Phase 2 (1)

Trial Status

Unknown2

Clinical Trials (2)

Showing 2 of 2 trials
NCT05619016Phase 2Unknown

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

NCT05587088Phase 1/2Unknown

Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)

Showing all 2 trials

Research Network

Common Treatments

  • 68gagaaby025 Pet1
  • Biopsy And Analysis Of Her2 Expression1
  • Petiveria Alliacea Preparation1

Active Sponsors

  • Hospital Universitario San Ignacio1
  • Karolinska University Hospital1
  • Pontificia Universidad Javeriana1

Top Investigators

Related Conditions

  • Acute Myeloid Leukemia In Relapse1
  • Acute Leukemia In Relapse1
  • Pancreatic Neoplasms1
  • Acute Leukemia1
  • Breast Cancer1

Activity Timeline